Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
BMJ Case Rep ; 14(4)2021 Apr 16.
Artigo em Inglês | MEDLINE | ID: mdl-33863763

RESUMO

Small-cell breast cancer is a very rare and aggressive type of neuroendocrine carcinoma. Histologically, it is indistinguishable from small-cell neuroendocrine lung cancer. Due to that, patients with small-cell neuroendocrine breast cancer should undergo examination of other areas of the body. Small-cell breast cancer may be treated with a combination of surgery, radiation therapy and chemotherapy. However, no standard treatment exists due to the small number of cases. We present a case of a 49-year-old woman with right breast primary small-cell neuroendocrine carcinoma.


Assuntos
Neoplasias da Mama , Carcinoma Neuroendócrino , Carcinoma de Células Pequenas , Neoplasias da Mama/diagnóstico , Carcinoma Neuroendócrino/diagnóstico , Carcinoma de Células Pequenas/diagnóstico , Feminino , Humanos , Pessoa de Meia-Idade
2.
Int J Surg Case Rep ; 82: 105866, 2021 May.
Artigo em Inglês | MEDLINE | ID: mdl-33862409

RESUMO

INTRODUCTION: Phyllodes tumours are rare breast neoplasms. It is especially rare in pregnancy. PRESENTATION OF CASE: We report a case of a 37-year-old woman with left breast benign phyllodes tumour, which started to grow very fast during pregnancy. The tumour was too big for breast-conserving surgery and it was necessary to remove the whole left breast. Patient underwent successful nipple-skin-sparing mastectomy with immediate silicone implant reconstruction. CONCLUSION: Breast phyllodes are classified as benign, borderline, and malignant. Standard treatment of breast phyllodes is surgery. The choice of surgery type depends on the tumour factors and breast size. We highlight that, inadequate treatment of phyllodes tumour can result to recurrence, growth, or even metastatic spread, when tumour has malignant potential.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...